The Indiana Alzheimer's Center will be established on the facilities at Indiana University School of Medicine. It will comprise four cores: an Administrative Core, a Clinical Core, a Neuropathological Core and an Education and Information Transfer Core. The Director of the Center will be Dr. Bernardino Ghetti, (Professor of Pathology and Psychiatry, Associate Director of the Division of Neuropathology and Associate Director of the Neurobiology Program) and two Associate Directors will be Drs. Hugh C. Hendrie (Albert E. Sterne Professor and Chairman of Psychiatry) and Michael Conneally (Distinguished Professor of Medical and Molecular Genetics and Neurology). The Center will draw upon the strengths of the faculty of Indiana University School of Medicine and its associated schools in particular its existing multi-disciplinary programs, the graduate program in medical neurobiology and the Geriatric Education Center to develop its research and educational agenda. The Principal Investigators in this project have an established record in research in AD and related disorders and have a long collaborative history with each other. The core faculty have already excellent community relationships and teaching programs through the operation of the existing Alzheimer's Disease and Related Disorders Clinic with the co-operation of the ADRDA and other community agencies. These programs will be enhanced and in particular a carefully evaluated educational intervention program for long term facilities will be developed. A major emphasis of the Center will be to reach out to the Afro-American community of Indianapolis and to involve them in the educational, clinical and research aspects of the program. The Clinical Core will allow the development of a cohort of carefully diagnosed patients with AD and related dementias together with normal subjects to participate in the research studies. The Center will combine the two major current research themes of the investigators at Indiana University; the search for the genetic basis of AD and the search for other risk factors into one basic and clinical program.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010133-05
Application #
2051373
Study Section
Neuroscience, Behavior and Sociology of Aging Review Committee (NBSA)
Project Start
1991-09-30
Project End
1996-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Pathology
Type
Schools of Medicine
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Groveman, Bradley R; OrrĂ¹, Christina D; Hughson, Andrew G et al. (2018) Rapid and ultra-sensitive quantitation of disease-associated ?-synuclein seeds in brain and cerebrospinal fluid by ?Syn RT-QuIC. Acta Neuropathol Commun 6:7
Zigon, Bob; Li, Huang; Yao, Xiaohui et al. (2018) GPU Accelerated Browser for Neuroimaging Genomics. Neuroinformatics 16:393-402
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Mustafa, Rafid; Brosch, Jared R; Rabinovici, Gil D et al. (2018) Patient and Caregiver Assessment of the Benefits From the Clinical Use of Amyloid PET Imaging. Alzheimer Dis Assoc Disord 32:35-42
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340

Showing the most recent 10 out of 604 publications